MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$494,450K
Cash and cash
equivalents
$240,634K
Accounts receivable
$106,446K
Assets held for sale
$87,510K
Prepaid expenses and
other current assets
$26,815K
Inventory
$11,545K
Restricted cash
$10,876K
Total current assets
$978,276K
Goodwill
$113,462K
Property and equipment,
net
$44,800K
Right-of-use asset, net
$22,897K
Other non-current
assets
$17,077K
Total assets
$1,176,512K
Accumulated deficit
-$4,568,148K
Treasury stock,
2,393,836 shares, cost...
$103,021K
Total liabilities and
stockholders deficit
$1,176,512K
Total stockholders
deficit
-$127,753K
Additional paid-in capital
$4,539,756K
Accumulated other
comprehensive income (loss)
$2,010K
Common stock, 0.01 par
value, 600,000,000...
$1,650K
Total liabilities
$1,304,265K
Total current
liabilities
$459,950K
Deferred revenue
$358,943K
Convertible notes payable
$244,213K
Other non-current
liabilities
$239,068K
Non-current finance lease
liabilities
$2,091K
Deferred revenue
$140,053K
Other current
liabilities
$137,778K
Accrued expenses
$107,165K
Liabilities held for sale
$47,869K
Accounts payable
$24,578K
Current portion of
finance lease...
$2,507K
Back
Back
Balance Sheet
source: myfinsight.com
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)